Alamar Biosciences (ALMR) vs Seer (SEER)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Alamar Biosciences is the larger company by market cap ($1.80 billion vs $120.2 million), about 15.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALMR | SEER |
|---|---|---|
| Share price | $25.91 | $2.17 |
| Market cap | $1.80B | $120.16M |
| 1-day change | -6.70% | -1.81% |
| YTD return | — | +18.58% |
| 1-year return | — | -3.56% |
| 5-year return | — | -93.42% |
| EPS (TTM) | $-1.20 | $-1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $39.61 | $2.41 |
| 52-week low | $18.85 | $1.55 |
| Distance from 52-week high | -34.59% | -9.96% |
| Analyst consensus | buy | none |
| Avg. price target upside | +36.63% | +84.33% |
| Average volume | 411.15K | 479.14K |
| Shares outstanding | 69.39M | 55.37M |
| Employees | 286 | 124 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Alamar Biosciences is about 15.0 times larger than Seer by market value ($1.80B vs $120.16M).
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 286 employees
About Seer
SEER stock →Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
Industrials · Biotechnology: Laboratory Analytical Instruments · 124 employees
ALMR vs SEER FAQ
Which is bigger, Alamar Biosciences or Seer?
Alamar Biosciences (ALMR) is larger, with a market capitalization of $1.80B compared with $120.16M for Seer (SEER).
Are Alamar Biosciences and Seer in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.